Tagged: 'BioMarin'

BioMarin Pharmaceutical snaps up Amicus Therapeutics for $4.8 billion

Friday, 19 December 2025 7:43 pm

Just when little old Betaville thought the recent biopharmaceutical dealmaking boom might have ended BioMarin Pharmaceutical pops up with a $4.8 billion takeover of Amicus Therapeutics, a US-listed rare metabolic disease drug developer.

BioMarin

Amicus Therapeutics

Exclusive to Betaville Intelligence subscribers

UNCOOKED ALERT: BioMarin said to ...

Monday, 01 March 2021 7:23 pmBioMarin, the US-listed rare disease drug developer, is at the centre of vague speculation.

BioMarin

Back on Tip TV talking about easyJet, BioMarin and Illumina

Monday, 22 August 2016 2:53 pmZak was down in the dumps today, so I cheered him up by blathering on for ten minutes about the curent red hot M&A market.

Sanofi said to weigh alternative deals to Medivation; eyes BioMarin pharmaceutical - sources - part 2

Monday, 22 August 2016 8:35 amNow, I wonder what Sanofi plans to next after missing out on the US biotech business it aggresively pursued for most of this year?

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources - part 2

Thursday, 21 July 2016 9:46 pmAccording to the Bloomberg story I read, Dr Schwan said Roche was looking at small to medium-sized acquistions although he believes biotech valuations are too high. Dr Schwan, though, refused to comment when the Bloomberg hack tried to elicit a denial or confirmation by asking him spefically about Roche's interest in BioMarin.

Bloomberg

BioMarin

Roche

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources

Wednesday, 06 July 2016 12:00 amRoche is said to be once again exploring a multi-billion takeover bid for US rare disease specialist BioMarin

Sanofi said to weigh alternative deals to Medivation; eyes BioMarin Pharmaceutical - sources

Friday, 17 June 2016 12:00 am

BioMarin Pharmaceutical snaps up Amicus Therapeutics for $4.8 billion

Friday, 19 December 2025 7:43 pm

BioMarin

Amicus Therapeutics

Exclusive to Betaville Intelligence subscribers

UNCOOKED ALERT: BioMarin said to ...

Monday, 01 March 2021 7:23 pmBioMarin, the US-listed rare disease drug developer, is at the centre of vague speculation.

BioMarin

Back on Tip TV talking about easyJet, BioMarin and Illumina

Monday, 22 August 2016 2:53 pmZak was down in the dumps today, so I cheered him up by blathering on for ten minutes about the curent red hot M&A market.

Sanofi said to weigh alternative deals to Medivation; eyes BioMarin pharmaceutical - sources - part 2

Monday, 22 August 2016 8:35 amNow, I wonder what Sanofi plans to next after missing out on the US biotech business it aggresively pursued for most of this year?

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources - part 2

Bloomberg

BioMarin

Roche

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources

Wednesday, 06 July 2016 12:00 amRoche is said to be once again exploring a multi-billion takeover bid for US rare disease specialist BioMarin

Sanofi said to weigh alternative deals to Medivation; eyes BioMarin Pharmaceutical - sources

Friday, 17 June 2016 12:00 am

Subscriptions

Independent Editorial

Tagged: 'BioMarin'

BioMarin Pharmaceutical snaps up Amicus Therapeutics for $4.8 billion

UNCOOKED ALERT: BioMarin said to ...

Back on Tip TV talking about easyJet, BioMarin and Illumina

Sanofi said to weigh alternative deals to Medivation; eyes BioMarin pharmaceutical - sources - part 2

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources - part 2

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources

Sanofi said to weigh alternative deals to Medivation; eyes BioMarin Pharmaceutical - sources

BioMarin Pharmaceutical snaps up Amicus Therapeutics for $4.8 billion

UNCOOKED ALERT: BioMarin said to ...

Back on Tip TV talking about easyJet, BioMarin and Illumina

Sanofi said to weigh alternative deals to Medivation; eyes BioMarin pharmaceutical - sources - part 2

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources - part 2

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources

Sanofi said to weigh alternative deals to Medivation; eyes BioMarin Pharmaceutical - sources